Shares rallied 19.1% following a standout quarter marked by an accretive IPO of the senior housing business, ongoing leasing momentum in outpatient medical properties, and an upgraded 2026 earnings outlook supported by strategic capital recycling and buybacks.

• Completed the Janus Living senior housing IPO, monetizing an 18% stake while maintaining exposure; current FFO from Janus portfolio valued at a ~20x multiple compared to Healthpeak’s.
• Executed $700M+ acquisitions ahead of IPO to capture significant multiple arbitrage; IPO proceeds expected to add approximately $0.04 per share in earnings once fully invested and stabilized.
• Outpatient Medical segment signed 1.1 million square feet of leases, achieving 5.4–5.8% cash re-leasing spreads, 79% tenant retention, and 91% total occupancy.
• Raised $170 million via joint venture recapitalization with Blackstone at 6.1% cap rate, with plans for additional $700 million+ transactions at cap rates significantly above implied stock valuation.
• Bought back $100 million of stock at >10% FFO yield, boosting 2026 guidance, while maintaining a 7.5% annualized dividend yield on a solid payout ratio.